Compare $BCLI vs $LSTA | Chartloom

Compare

$BCLI vs $LSTA

Brainstorm Cell Therapeutics Inc · Lisata Therapeutics Inc

BCLI

Brainstorm Cell Therapeutics Inc

LSTA

Lisata Therapeutics Inc

Compare $BCLI vs $LSTA

Comparing Brainstorm Cell Therapeutics Inc and Lisata Therapeutics Inc

BCLIBrainstorm Cell Therapeutics Inc

LSTALisata Therapeutics Inc

BCLIBrainstorm Cell Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

54.9%

52W performance

30.1%

FCF yield

-21.1%

LSTALisata Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-90.7%

YTD performance

-45.9%

52W performance

-58.1%

FCF yield

-127.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BCLI

LSTA

Detailed metrics comparison

BCLI

Brainstorm Cell Therapeutics Inc

LSTA

Lisata Therapeutics Inc

Market Cap

BCLI$10M

LSTA$10M

Enterprise Value

BCLI$12M

LSTA$-786K

Price

BCLI$0.95

LSTA$1.06

P/E Ratio

BCLIN/A

LSTAN/A

P/S Ratio

BCLI0.00x

LSTA96.57x

EV/Sales

BCLI0.00x

LSTA-7.86x

EV/EBITDA

BCLI0.00x

LSTA0.00x

P/B Ratio

BCLI7.31x

LSTA1.61x

P/FCF Ratio

BCLIN/A

LSTAN/A

EV/FCF

BCLI-5.29x

LSTA0.06x

PEG Ratio

BCLIN/A

LSTAN/A

Forward P/E (NTM)

BCLIN/A

LSTAN/A

Forward P/S (NTM)

BCLIN/A

LSTAN/A

Revenue (TTM)

BCLI$0

LSTA$100K

Revenue Growth (YoY)

BCLIN/A

LSTA-90.7%

Forward Rev Growth

BCLI53.7%

LSTA44.0%

Gross Margin (TTM)

BCLI0.0%

LSTA9.5%

Operating Margin (TTM)

BCLI0.0%

LSTA0.0%

EBITDA Margin (TTM)

BCLI0.0%

LSTA-11423.0%

Net Margin (TTM)

BCLI0.0%

LSTA-10132.0%

FCF Margin (TTM)

BCLIN/A

LSTA-12323.0%

Net Income (TTM)

BCLI$-7M

LSTA$-10M

FCF (TTM)

BCLI$-2M

LSTA$-12M

EPS (TTM)

BCLI-$0.61

LSTA-$1.11

ROE (TTM)

BCLI-23636.0%

LSTA-7510.0%

ROA (TTM)

BCLI-33822.0%

LSTA-6015.0%

ROIC (TTM)

BCLI-23636.0%

LSTA-7510.0%

Cash

BCLI$22K

LSTA$10M

Debt

BCLI$1M

LSTA$0

Net Cash/Debt

BCLI$-1M

LSTA$10M

Current Ratio (TTM)

BCLI0.21x

LSTA3.69x

Quick Ratio (TTM)

BCLI0.16x

LSTA3.50x

Debt/Equity (TTM)

BCLI0.00x

LSTA0.00x

Debt/Assets (TTM)

BCLI0.0%

LSTA0.0%

Interest Coverage (TTM)

BCLIN/A

LSTAN/A

Net Debt/EBITDA (TTM)

BCLI0.00x

LSTA0.00x

Beta

BCLI0.39

LSTA0.97

52W Performance

BCLI30.1%

LSTA-58.1%

YTD Performance

BCLI54.9%

LSTA-45.9%

% from 52W High

BCLI-43.8%

LSTA-79.1%

% from 52W Low

BCLI106.9%

LSTA7.3%

Asset Turnover (TTM)

BCLI0.00x

LSTA0.01x

FCF Yield (TTM)

BCLI-21.1%

LSTA-127.6%

Earnings Yield (TTM)

BCLI-64.2%

LSTA-104.9%

Dividend Yield (TTM)

BCLIN/A

LSTAN/A

Rule of 40

BCLI0.0

LSTA-12,413.7

EV/GP/RG

BCLIN/A

LSTAN/A

Ticker research

View BCLI research View LSTA research

Metric	BCLI Brainstorm Cell Therapeutics Inc	LSTA Lisata Therapeutics Inc
Market & Valuation
Market Cap	$10M	$10M
Enterprise Value	$12M	$-786K
Price	$0.95	$1.06
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	96.57x
EV/Sales	0.00x	-7.86x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.31x	1.61x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.29x	0.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$100K
Revenue Growth (YoY)	N/A	-90.7%
Forward Rev Growth	53.7%	44.0%
Profitability
Gross Margin (TTM)	0.0%	9.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-11423.0%
Net Margin (TTM)	0.0%	-10132.0%
FCF Margin (TTM)	N/A	-12323.0%
Net Income (TTM)	$-7M	$-10M
FCF (TTM)	$-2M	$-12M
EPS (TTM)	-$0.61	-$1.11
ROE (TTM)	-23636.0%	-7510.0%
ROA (TTM)	-33822.0%	-6015.0%
ROIC (TTM)	-23636.0%	-7510.0%
Financial Health
Cash	$22K	$10M
Debt	$1M	$0
Net Cash/Debt	$-1M	$10M
Current Ratio (TTM)	0.21x	3.69x
Quick Ratio (TTM)	0.16x	3.50x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.39	0.97
52W Performance	30.1%	-58.1%
YTD Performance	54.9%	-45.9%
% from 52W High	-43.8%	-79.1%
% from 52W Low	106.9%	7.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-21.1%	-127.6%
Earnings Yield (TTM)	-64.2%	-104.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-12,413.7
EV/GP/RG	N/A	N/A
Ticker research	View BCLI research	View LSTA research

Valuation

P/S Ratio

BCLI

0.00x

LSTA

96.57x

EV/FCF

BCLI

-5.29x

LSTA

0.06x

Growth & revenue

Revenue Growth TTM

LSTA

-90.7%

Forward Revenue Growth

BCLI

53.7%

LSTA

44.0%

Profitability & performance

Gross Margin

LSTA

9.5%

BCLI

0.0%

ROE

LSTA

-7510.0%

BCLI

-23636.0%

FCF Yield %

BCLI

-21.1%

LSTA

-127.6%

52-Week Performance

BCLI

30.1%

LSTA

-58.1%

Detailed metrics comparison

BCLI

Brainstorm Cell Therapeutics Inc

LSTA

Lisata Therapeutics Inc

Market Cap

BCLI$10M

LSTA$10M

Enterprise Value

BCLI$12M

LSTA$-786K

Price

BCLI$0.95

LSTA$1.06

P/E Ratio

BCLIN/A

LSTAN/A

P/S Ratio

BCLI0.00x

LSTA96.57x

EV/Sales

BCLI0.00x

LSTA-7.86x

EV/EBITDA

BCLI0.00x

LSTA0.00x

P/B Ratio

BCLI7.31x

LSTA1.61x

P/FCF Ratio

BCLIN/A

LSTAN/A

EV/FCF

BCLI-5.29x

LSTA0.06x

PEG Ratio

BCLIN/A

LSTAN/A

Forward P/E (NTM)

BCLIN/A

LSTAN/A

Forward P/S (NTM)

BCLIN/A

LSTAN/A

Revenue (TTM)

BCLI$0

LSTA$100K

Revenue Growth (YoY)

BCLIN/A

LSTA-90.7%

Forward Rev Growth

BCLI53.7%

LSTA44.0%

Gross Margin (TTM)

BCLI0.0%

LSTA9.5%

Operating Margin (TTM)

BCLI0.0%

LSTA0.0%

EBITDA Margin (TTM)

BCLI0.0%

LSTA-11423.0%

Net Margin (TTM)

BCLI0.0%

LSTA-10132.0%

FCF Margin (TTM)

BCLIN/A

LSTA-12323.0%

Net Income (TTM)

BCLI$-7M

LSTA$-10M

FCF (TTM)

BCLI$-2M

LSTA$-12M

EPS (TTM)

BCLI-$0.61

LSTA-$1.11

ROE (TTM)

BCLI-23636.0%

LSTA-7510.0%

ROA (TTM)

BCLI-33822.0%

LSTA-6015.0%

ROIC (TTM)

BCLI-23636.0%

LSTA-7510.0%

Cash

BCLI$22K

LSTA$10M

Debt

BCLI$1M

LSTA$0

Net Cash/Debt

BCLI$-1M

LSTA$10M

Current Ratio (TTM)

BCLI0.21x

LSTA3.69x

Quick Ratio (TTM)

BCLI0.16x

LSTA3.50x

Debt/Equity (TTM)

BCLI0.00x

LSTA0.00x

Debt/Assets (TTM)

BCLI0.0%

LSTA0.0%

Interest Coverage (TTM)

BCLIN/A

LSTAN/A

Net Debt/EBITDA (TTM)

BCLI0.00x

LSTA0.00x

Beta

BCLI0.39

LSTA0.97

52W Performance

BCLI30.1%

LSTA-58.1%

YTD Performance

BCLI54.9%

LSTA-45.9%

% from 52W High

BCLI-43.8%

LSTA-79.1%

% from 52W Low

BCLI106.9%

LSTA7.3%

Asset Turnover (TTM)

BCLI0.00x

LSTA0.01x

FCF Yield (TTM)

BCLI-21.1%

LSTA-127.6%

Earnings Yield (TTM)

BCLI-64.2%

LSTA-104.9%

Dividend Yield (TTM)

BCLIN/A

LSTAN/A

Rule of 40

BCLI0.0

LSTA-12,413.7

EV/GP/RG

BCLIN/A

LSTAN/A

Ticker research

View BCLI research View LSTA research

Metric	BCLI Brainstorm Cell Therapeutics Inc	LSTA Lisata Therapeutics Inc
Market & Valuation
Market Cap	$10M	$10M
Enterprise Value	$12M	$-786K
Price	$0.95	$1.06
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	96.57x
EV/Sales	0.00x	-7.86x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.31x	1.61x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.29x	0.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$100K
Revenue Growth (YoY)	N/A	-90.7%
Forward Rev Growth	53.7%	44.0%
Profitability
Gross Margin (TTM)	0.0%	9.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-11423.0%
Net Margin (TTM)	0.0%	-10132.0%
FCF Margin (TTM)	N/A	-12323.0%
Net Income (TTM)	$-7M	$-10M
FCF (TTM)	$-2M	$-12M
EPS (TTM)	-$0.61	-$1.11
ROE (TTM)	-23636.0%	-7510.0%
ROA (TTM)	-33822.0%	-6015.0%
ROIC (TTM)	-23636.0%	-7510.0%
Financial Health
Cash	$22K	$10M
Debt	$1M	$0
Net Cash/Debt	$-1M	$10M
Current Ratio (TTM)	0.21x	3.69x
Quick Ratio (TTM)	0.16x	3.50x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.39	0.97
52W Performance	30.1%	-58.1%
YTD Performance	54.9%	-45.9%
% from 52W High	-43.8%	-79.1%
% from 52W Low	106.9%	7.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-21.1%	-127.6%
Earnings Yield (TTM)	-64.2%	-104.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-12,413.7
EV/GP/RG	N/A	N/A
Ticker research	View BCLI research	View LSTA research